Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ The FDA will clear the Pfizer vaccine for children aged 12 to 15 next week, the report said.

The FDA will clear the Pfizer vaccine for children aged 12 to 15 next week, the report said.



The Food and Drug Administration is preparing to authorize the Pfizer vaccine for children aged 12 to 15, according to a New York Times report. The permit could be announced later this week, according to unnamed federal officials. This comes weeks after Pfizer reported that none of the teenagers in the company’s clinical trials had developed symptomatic COVID-19. An FDA spokesman was pressured into a potential statement, saying: “We can assure the public that we are working to review this request as quickly and transparently as possible.” Pharmaceutical rival Moderna is also expected to have ready-made data from a study with children aged between 1

2 and 17 years, followed by another study involving 6-month-olds to 12-year-olds. However, some, such as John Hopkins epidemiologist Jennifer Nutso, wonder why the United States prioritizes vaccinating children who are at “low risk of serious complications from the virus,” while others do not have enough vaccine for their high-risk populations.

Read it on New York Times


Source link